IB Acquisition Corp. (NASDAQ:IBACU) announced the pricing of its $100 million IPO and its units are expected to begin trading on the Nasdaq under the symbol “IBACU”, Tuesday, March 26, 2024.
The new SPAC will have a broad search focus and will not be limited to a particular geographic region or industry, but believe there are compelling investment opportunities in a number of areas including fintech, healthcare and life sciences, sports and entertainment, and consumer goods.
IB Acquisition Corp’s sponsor team will be led by Adelmo “Al” Lopez, as Chairman and Chief Executive Officer, with Christy Albeck serving as Chief Financial Officer, and John Joyce as Vice Chairman. Silvia Panigone and Jian Zhang serve as Directors.
Total SPAC deal count for 2024 year-to-date is now 6. This offering is expected to close on Thursday, March 28, 2024.
I-Bankers Securities, Inc. and IB Capital LLC are acting as joint book-running managers of the offering. ArentFox Schiff LLP is serving as Issuer’s Counsel with Ellenoff Grossman & Schole LLP serving as Underwriter’s Counsel. UHY LLP serves as auditor. Continental Stock Transfer & Trust Company is acting as trustee.
At the SPAC of Dawn Dealmakers remain confident that AI is going to play a big role in their M&A processes, but feel unprepared for some the changes, according to a new survey of 225 corporate and 75 private equity transactions professionals. SS&C subsidiary Mergermarket generated the report that found more than half of respondents...
Trailblazer Merger I (NASDAQ:TBMC) has entered into a definitive agreement to combine with data intelligence firm Cyabra at an enterprise value of $70 million. Tel Aviv-based Cyabra provides tools to corporations and governments to identify fake accounts and combat social media disinformation. The combined company is expected to trade on the Nasdaq once the deal...
Chain Bridge I (NASDAQ:CBRG) has entered into a definitive agreement to combine with cannabinoid pharmaceuticals firm Phytanix Bio at a pre-deal valuation of $58 million. Santa Barbara, California-based Phytanix is working to develop bladder and seizure treatments using cannabis-based substances. The combined company is expected to trade on the Nasdaq under the symbol “PHYX” once...
At the SPAC of Dawn A new ripple is expected to come to the market today in the form of Ethereum spot ETFs after the SEC gave final approval to several yesterday. BlackRock, Fidelity, Bitwise, Franklin, and VanEck all received approval for their new funds and all but BlackRock plan to waive fees until they...
Maquia Capital (NASDAQ:MAQC) has entered into a definitive agreement to combine with AI infrastructure firm Velocium at a valuation of $445 million. Miami-based Velocium is developing data center processors designed to be particularly efficient for use by AI applications and Web 3.0. The combined company is expected to trade on the Nasdaq under the symbol...